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Abstract Transformingandinsulin-likegrowthfactorsare
important in regulating bone mass. Thus, one would antici-
pate correlations between matrix concentrations of growth
factors and functional properties of bone. We therefore
investigated the relationships of (1) TGF-b2 and (2) IGF-I
matrix concentrations with the trabecular microstructure,
stress distribution, and mechanical properties of tibial
cancellous bone from six male human cadavers. Tra-
becular stress ampliﬁcation (VMExp/rapp) and variability
(VMCOV) were calculated using microcomputed tomogra-
phy (lCT)-based ﬁnite element simulations. Bone volume
fraction (BV/TV),surface/volumeratio(BS/BV),trabecular
thickness (Tb.Th), number (Tb.N) and separation (Tb.Sp),
connectivity (Eu.N), and anisotropy (DA) were measured
using 3-D morphometry. Bone stiffness and strength were
measured by mechanical testing. Matrix concentrations of
TGF-b2 and IGF-I were measured by ELISA. We found
higher matrix concentrations of TGF-b2 were associated
with higher Tb.Sp and VMExp/rapp for pooled data and
within subjects. Similarly, a higher matrix concentration of
IGF-I was associated with lower stiffness, strength, BV/TV
and Tb.Th and with higher BS/BV, Tb.Sp,VMExp/rapp and
VMCOV for pooled data and within subjects. IGF-I and
Tb.N were negatively associated within subjects. It appears
variations of the stress distribution in cancellous bone cor-
relatewiththevariationoftheconcentrationsofTGF-b2and
IGF-I in bone matrix: increased local matrix concentrations
of growth factors are associated with poor biomechanical
and architectural properties of tibial cancellous bone.
Introduction
Transforming growth factor b1 (TGF-b1), TGF-b2 and
insulin-like growth factors (IGF-I and IGF-II) are believed
important local regulators of osteoblast and osteoclast
activity [2, 12]. These growth factors can be synthesized
and stored in bone matrix during bone formation, released
during bone resorption and affect bone remodeling [21,
44]. There is substantive evidence that TGF-bs and IGFs,
speciﬁcally TGF-b2 and IGF-I, affect osteoblastic cell
proliferation, differentiation, and survival [5, 19, 37, 60,
62]. Insulin-like growth factor-I also regulates bone
resorption by enhancing osteoclast activity [24, 31, 44].
TGF-b can affect osteoclast differentiation and survival
and, depending on the dose, can enhance or reduce
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loading also affect the IGF and TGF-b expression in
osteocytes [39, 40, 51, 52, 70].
The importance of TGF-bs and IGF-I in the control of
bone growth and remodeling is further established by
rodent models. In genetically modiﬁed mice, enhanced
bone mass and enhanced stiffness, strength and mineral
concentration of the cortical bone matrix are generally
associated with reduced TGF-b signaling [3, 20, 23].
Cancellous bone volume fraction is higher in the IGF-I
deﬁcient mice than in the wild type [4]. On the other hand,
over-expression of IGF-I in the osteoblasts of transgenic
mice also causes an increase in the cancellous bone volume
fraction in transgenic mice [45]. While subcutaneous
administration of IGF-I to adult rats can reduce trabecular
bone formation [61], local administration of IGF-I to old
rats can increase the trabecular bone volume [63].
Studies with human bone tissue indicate that bone
matrix concentrations of TGF-b1, TGF-b2, and IGF-I are
related to aging, metabolic bone disease, and fracture risk
but the relationships may be gender and skeletal site
dependent [1, 7, 29, 38, 46, 49, 50, 54, 57, 64]. A few
studies have examined the relationships of local matrix
TGF-b1, TGF-b2, and IGF-I with bone mass and
mechanical properties in human bone, however, the results
have been conﬂicting [1, 46, 56, 57]. For example, despite
strong demonstrations in animal experiments, an associa-
tion between bone volume fraction and the matrix
concentrations of TGF- b1 or TGF-b2 was not found in the
human iliac crest, femoral shaft, or lumbar spine [6, 50].
The matrix concentration of IGF-I is correlated with bone
density in the iliac crest and lumbar spine [49, 57], but not
in the proximal femoral shaft, femoral neck, or Ward’s
triangle [49, 56]. Apparent density and stiffness differences
between the superior and inferior regions of the human
femoral head are also not accompanied by differences in
the matrix concentrations of IGF-I or IGF-II [58].
Our previous work demonstrated the matrix concentra-
tion of IGF-I in cancellous bone is negatively correlated
with the bone volume fraction, strength, and stiffness of
cancellous bone from proximal tibiae of human male
cadavers within subjects [18]. The current objectives were
(1) to examine the relationship of TGF-b2 with the
mechanical, microarchitectural, and stress distribution
properties and (2) to examine the relationship of IGF-I
matrix levels with the microarchitectural and stress distri-
bution properties of tibial cancellous bone.
Materials and Methods
Right tibiae from six male human cadavers that were free
of bone and joint disease (average age, 48 ± 14 years;
range, 26–63 years) were utilized. A total of 45 cylindrical
specimens of cancellous bone were prepared. These are the
same specimens used in our previous study [18]; the details
of specimen processing have been previously described.
Brieﬂy, bone slabs were sectioned from the proximal tibiae
such that the subchondral bone plate was completely
removed at the center of the condyles during the ﬁrst cut.
The second cut was made 35 mm distal to the ﬁrst cut.
From the 35-mm-thick slab of cancellous bone, cancellous
bone cores (diameter, 8 mm) were cut out using a dia-
mond-tipped coring tool (Starlite, Rosemont, PA). Starting
6 mm distal to the proximal end of the core, each core was
trimmed to a 10-mm-long cylinder. Because we were
interested in within-individual variations rather than an
anatomic site effect, as many cores as possible were cut out
from each slab to represent the entire section but their exact
location in the transverse plane was not recorded. All
specimens were then scanned by a 3-D microcomputed
tomography (lCT) system with a resolution of 21 lm
using previously developed techniques [26, 53].
lCT images were used to construct ﬁnite element (FE)
models by directly converting image voxels representing
bone tissue to eight-node hexahedral ﬁnite elements using a
specialpurposeprogram[26,32].Thetrabecularbonetissue
in the model was assumed isotropic and uniform with a
Young’s modulus of 5 GPa and a Poisson’s ratio of 0.3.
Prescribed displacements equivalent to 0.5% strain were
applied in the longitudinal direction through sliding inter-
faces on the top and bottom surfaces of the cylinder with all
other surfaces unconstrained. The apparent uniaxial stress
(rapp) was calculated by summing nodal reaction forces and
dividing by the apparent cross-sectional area of specimens.
The mean (VMExp) and standard deviation (VMSD) of
trabecularvonMisesstressdistributionwerecalculatedfrom
a three-parameter Weibull cumulative probability function
ﬁttedtothestressdistributionforeachspecimen[25,65–67].
The variability of trabecular shear stress was expressed as
the coefﬁcient of variation: VMCOV = VMSD/VMExp.
The magnitude of trabecular shear stress was expressed as
the average trabecular shear stress per apparent superoinfe-
rior uniaxial stress (VMExp/rapp). Both VMExp/rapp and
VMCOV are considered structural indices of shear stress
concentration in the hard tissue [25, 66, 68, 69].
A custom-written program was used to compute archi-
tectural parameters from lCT images [22, 28, 36]. Bone
volume fraction (BV/TV), bone surface-to-volume ratio
(BS/BV), trabecular thickness (Tb.Th), trabecular number
(Tb.N), and trabecular separation (Tb.Sp) were calculated
using 3-D stereology principles. Connectivity (Eu.N) of the
trabecular network was calculated using the topological
approach based on the Euler-Poincare number [47]. The
degree of anisotropy (DA) was calculated as the maximum
to minimum mean intercept length ratio.
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of cylindrical cancellous bone samples under uniaxial
compression was reported in the previous study [18]. These
modulus and strength data were used to correlate
mechanical properties with matrix concentrations of
growth factors in our study.
Growth factor extraction methods were as described in
our previous study [18]. Cancellous bone cylinders were
ground into small particles using a biopulverizer (BioSpec
Products, Inc., Bartlesville, OK). The particles were placed
within dialysis units (Slide-A-Lyzer
1, MW cutoff = 3500,
Pierce, Rockford, IL) and growth factors extracted by
dialysis against 4 M guanidine hydrochloride, 30 mM Tris
(pH 7.4), 0.05 M EDTA, and a mixture of protease
inhibitors at 4C for 48 hours. Bone residue and extract
were separated by centrifugation at 10,000 rpm for
5 minutes. The extracts were redialyzed against phosphate
buffer saline solution for 72 hours and then stored at
20C until subsequent assay.
TGF-b2 generally exists as a latent form in bone matrix,
requiring activation before it can exert biological activities
[2]. In order to activate latent TGF-b2, the supernatant
extracted from bone samples was acidiﬁed by addition of
25 ll of 1 M HCl to 125 ll extract sample and neutralized
with 25 ll 1.2 M NaOH/0.5 M HEPES. Meanwhile, in
order to avoid the IGF-binding protein artifacts, the super-
natant extracted from bone samples was pretreated (10 min)
to release IGF-I from binding proteins by the use of an
acidic buffer (pretreatment reagent, composition proprie-
tary, IGF1 ELISA assay R&D Systems, Minneapolis, MN).
The concentrations of TGF-b2 and IGF-I in bone matrix
were determined by sandwich enzyme-linked immunosor-
bent assay (ELISA, R&D Systems, Minneapolis, MN) in
accordance with the manufacturer’s instructions. Duplicate
assays were performed for each extract, and the results
were averaged. The sensitivity of TGF-b and IGF-I assays
were determined to be 0.75 ng/g and 2.79 ng/g, respec-
tively. The matrix concentrations of TGF-b2 and IGF-I
were expressed as growth factor concentration per dry
weight of the bone powder. Initial studies demonstrated
that TGF-b1, TGF-b2, and IGF-I could be efﬁciently iso-
lated from powdered human bone using two 24 hours
extractions in guanidine (4 M) EDTA (0.05 M), 0.03 M
Tris buffer. Growth factor concentrations were within the
range of those previously reported. (TGF-b1: From 250 ±
0.34 ng/g for lumbar spine to 710 ± 400 ng/g for femoral
head; TGF-b2: 9.29 ± 4.72 ng/g for lumbar spine to 14.48
± 4.63 for femoral shaft; IGF-I: 80-870 ng/g for iliac crest
to *300–1000 ng/g for femur) [50, 56, 57]. The concen-
trations of TGF-b2 and IGF-I in the series of bone samples
in the present study was within the range of initial analyses,
however; TGF-b1 concentrations were considerably lower
than those obtained in our initial analyses and lower than
the previously published range. As we have no reasonable
explanation for this discrepancy, the TGF-b1 data have not
been included in the present analysis.
Correlation analysis was used to test the presence of
relationships between matrix growth factor densities and
other cancellous bone properties. Regression analysis was
performed to examine the relationships. The relationships
betweengrowthfactorsandparameterswithinasubjectwere
examined using mixed models in which each subject was
treated as a random effect. JMP (SAS Institute, Cary, NC)
was used for the analyses. Because there was no more than
one subject at a given age, the mixed modelsthat used donor
as a variable would automatically address age variations in
the data. Therefore, results were not adjusted for age.
An adjustment for p values was calculated for multiple
tests, taking into account the correlations between multiple
factors [55]. This calculation suggested a p value of 0.012
corresponding to a = 0.05.
Results
Matrix concentration of TGF-b2 was positively associated
with Tb.Sp and VMExp/rapp for pooled data (Table 1;
Fig. 1) and within subjects (Table 2; Figs. 2, 3).
Matrix concentration of IGF-I was associated with lower
stiffness, strength, BV/TV, and Tb.Th and with higher BS/
BV, Tb.Sp, VMExp/rapp, and VMCOV for pooled data
(Table 1; Figs. 1, 4, 5) and within subjects (Table 2;
Figs. 6, 7). IGF-I and Tb.N were negatively associated
within subjects (Table 2).
Discussion
Biomechanical properties of bone tissue are inﬂuenced by
bone remodeling, in which growth factors play an impor-
tant role. Our objectives were to investigate the
relationships of matrix concentrations of (1) TGF-b2 and
(2) IGF-I with biomechanical, microarchitectural, and tra-
becular stress distribution properties of cancellous bone in
the proximal tibiae of men.
We note several limitations. First, the proximal tibia is
not a site of common osteoporotic fractures. However, it
does experience cancellous bone density and architectural
changes with age [16, 17], ligament injury [35, 41] knee
replacement [42] and osteoarthritis [34, 71]. Therefore, we
believe studies of the proximal tibial bone are relevant to
the understanding of degenerative diseases and the design,
ﬁxation and durability of total joint prostheses of the knee.
Second, our study is correlational and although the results
support a relationship between growth factor signaling and
mechanical property regulation, causation cannot be
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123established from the current data. Third is the use of a
constant tissue modulus in ﬁnite element analyses of can-
cellous bone. The stress distribution properties calculated
from FE models are expected to be different between
homogenous and variable-modulus models [8] but not to
the extent that our conclusions would be affected. Finally,
the architectural parameters examined in this study are
based on stereological principles. Stereology-based
Table 1. Degree of freedom-adjusted coefﬁcients of determination
(radj
2 ) and p values associated with the effect of TGF-b2 and IGF-I on
mechanical and architectural properties of cancellous bone in simple
linear regression
Response ; Effect ? TGF-b2 IGF-1
Eapp radj
2 = 0.010;
p = 0.457 ()
radj
2 = 0.197;
p = 0.001 ()
ru radj
2 = 0.005;
p = 0.273 ()
radj
2 = 0.222;
p = 0.000 ()
VMCOV radj
2 = 0.050;
p = 0.074 (+)
radj
2 = 0.278;
p = 0.000 (+)
VMExp/rapp radj
2 = 0.088;
p = 0.027 (+)
radj
2 = 0.222;
p = 0.000 (+)
BV/TV radj
2 = 0.035;
p = 0.115 ()
radj
2 = 0.226;
p = 0.000 ()
BS/BV radj
2 = 0.040;
p = 0.100 (+)
radj
2 = 0.239;
p = 0.000 (+)
Tb.Th radj
2 = 0.032;
p = 0.125 ()
radj
2 = 0.205;
p = 0.001 ()
Tb.N radj
2 = 0.045;
p = 0.086 ()
radj
2 = 0.185;
p = 0.001 ()
Tb.Sp radj
2 = 0.105;
p = 0.016 (+)
radj
2 = 0.213;
p = 0.000 (+)
Eu.N radj
2 = 0.023*;
p = 0.871 ()
radj
2 = 0.023*;
p = 0.889 ()
DA radj
2 = 0.020;
p = 0.176 ()
radj
2 = 0.051;
p = 0.073 ()
* A negative radj
2 means the assumption of a linear relationship is
worse than the assumption of a constant. The sign in parentheses
show whether the relationship is negative or positive.
0
5
10
15
20
25
30
35
40
0 0.2 0.4 0.6 0.8 1 1.2
Nondimensional TGF-β2 and IGF-I
V
M
E
x
p
/
σ
a
p
p
TGF-b2
IGF-I
Linear (TGF-b2)
Linear (IGF-I)
Fig. 1 Magnitude of trabecular shear stresses (VMExp/rapp)
increases with increasing matrix concentrations of TGF-b2 and
IGF-I in the same bone. The growth factor values are normalized
using the maximum of each type of measurement for ease of
comparison.
Table 2. Degree of freedom-adjusted coefﬁcients of determination
(radj
2 ) and p values associated with the effect of TGF-b2 and IGF-I on
mechanical and architectural properties of cancellous bone in mixed
models
Response ; Effect ? TGF-b2 IGF-1
Eapp radj
2 = 0.300;
p = 0.496 ()
radj
2 = 0.376;
p = 0.015 ()
ru radj
2 = 0.380;
p = 0.184 ()
radj
2 = 0.460;
p = 0.006 ()
VMCOV radj
2 = 0.290;
p = 0.156 (+)
radj
2 = 0.425;
p = 0.003 (+)
VMExp/rapp radj
2 = 0.484;
p = 0.011 (+)
radj
2 = 0.561;
p = 0.000 (+)
BV/TV radj
2 = 0.578;
p = 0.110 ()
radj
2 = 0.599;
p = 0.021 ()
BS/BV radj
2 = 0.290;
p = 0.098 (+)
radj
2 = 0.469;
p = 0.000 (+)
Tb.Th radj
2 = 0.288;
p = 0.112 ()
radj
2 = 0.442;
p = 0.002 ()
Tb.N radj
2 = 0.636;
p = 0.088 ()
radj
2 = 0.618;
p = 0.204 ()
Tb.Sp radj
2 = 0.609;
p = 0.011 (+)
radj
2 = 0.580;
p = 0.039 (+)
Eu.N radj
2 = 0.421;
p = 0.419 ()
radj
2 = 0.427;
p = 0.416 (+)
DA radj
2 = 0.367*;
p = 0.050 ()
radj
2 = 0.194*;
p = 0.278 ()
* A negative radj
2 means the assumption of a linear relationship is
worse than the assumption of a constant. The sign in parentheses
show whether the relationship is negative or positive.
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Fig. 2 Mixed model ﬁt to VMExp/rapp indicated a positive linear
trend with TGF-b2 within an individual tibia.
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123calculation of microstructural parameters (other than BV/
TV, Eu.N and DA) results in values that are different from
those obtained by direct calculation [15, 30] but micro-
structural parameters calculated using one method are
highly correlated to those calculated using the other
method [15].
We did not ﬁnd a relationship between TGF-b2 and
cancellous bone strength or stiffness. This is similar to
results from other human bone studies that failed to ﬁnd an
association between bone volume and matrix TGF-b1o r
TGF-b2[ 6, 50]. However, it is in contrast with results from
a genetically modiﬁed mouse study where reduced TGF-b
signaling was associated with enhanced cortical bone
strength and stiffness [3].
We did ﬁnd an increase in Tb.Sp and VMExp/rapp with
increasing matrix levels of TGF-b2. These results are
consistent with TGF-b overexpression and inhibition
studies in animals where increased TGF-b expression is
associated with lower bone mass [20, 23]. The effect of the
microstructure is separated from that of matrix properties
in our stereology and FE analyses. Based on the presence
of a relationship of TGF-b with microstructural properties
but not with stiffness and strength, further work focusing
on the relationship between growth factor concentrations
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Fig. 3 Mixed model ﬁt to trabecular separation (Tb.Sp) indicated a
positive linear trend with TGF-b2 within an individual tibia.
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Fig. 4 Apparent strength of cancellous bone decreases with increas-
ing matrix concentrations of TGF-b2 (NS) and IGF-I in the same
bone. The growth factor values are normalized using the maximum of
each type of measurement for ease of comparison. Because the linear
ﬁt to the IGF-I data passes through ru = 0 within the range of
measured IGF-I values, it was deemed inadequate. A power-ﬁt,
although equally explanatory (radj
2 = 0.238, p\0.001) as the linear
model (radj
2 = 0.222, p\0.001), is presented as a simple function to
illustrate the nonlinear nature of the relationship.
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Fig. 5 Coefﬁcient of variation of trabecular shear stresses (VMCOV)
increases with increasing matrix concentrations of TGF-b2 (NS) and
IGF-I in the same bone. The growth factor values are normalized
using the maximum of each type of measurement for ease of
comparison.
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Fig. 6 Mixed model ﬁt to VMExp/rapp indicated a positive linear
trend with IGF-I within an individual tibia.
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123and matrix mechanical properties in human bone may be
warranted [3].
Decreasing cancellous bone strength and stiffness with
increasing matrix concentration of IGF-I has been reported
previously [18]. The increasing VMExp/rapp, VMCOV,
BS/BV and Tb.Sp as well as decreasing BV/TV, Tb.Th and
Tb.N with increasing IGF-I is consistent with the strength
and stiffness results from the same bones and bone volume
results from IGF-I-deﬁcient mice [4]. Negative relationship
between architectural parameters and IGF-I matrix con-
centration within individual subjects is in contrast with a
previous study in which a positive relationship between
skeletal IGF-I concentration and bone volume fraction of
cancellous bone from iliac biopsies was observed [57].
This inconsistency may be due to donor differences as the
tissue in the Seck study was obtained from female donors
with breast cancer. The difference between the results may
also indicate that the effect of local IGF-I on bone is site-
speciﬁc; site speciﬁcity can be between different bones and
between different regions of the same bone. The IGF reg-
ulatory system is relatively complex and other components
of this system such as insulin-like growth factor binding
proteins (IGFBPs) may be involved in modulating the
action of IGF-I on remodeling. The production of IGFBPs
in human bone cells under similar conditions is different
between cells from different skeletal sites [43] that may
explain, in part, the site-speciﬁc relationship of IGF-I with
bone mass.
Increasing levels of BV/TV, modulus and strength with
decreasing levels of growth factors in our study may be
associated with an adaptive response of bone to increasing
mechanical demands in these bone regions. This idea is
consistent with the ﬁnding that matrix deposition of both
IGF-I and TGF-b1 decreases as the result of increased
mechanical loading in rats exercised on a treadmill [9].
Experiments with rat osteoblast cultures indicate that pro-
liferation associated with estrogen and testosterone is
mediated by IGF-I whereas proliferation associated with
mechanical strain is not [10, 13, 14]. On the other hand,
increased mechanical loading causes a strong expression of
IGF-I mRNA in the osteocyte as reported in rat caudal
vertebrae and cortical bone in vivo mechanical loading
experiments [39, 40, 51, 52]. TGF-b increases IGF-I
expression in human osteoblast cells [48]. The response of
TGF-b to mechanical stimulation depends on the TGF-b
isoform, nature of the mechanical perturbation, cell type
considered, and the anatomic site [59, 70] but methodo-
logic differences such as mRNA expression versus matrix
concentration of the protein and in vitro versus in vivo
model systems may amplify these dependencies. Overall,
these data suggest that mechanical strain-related prolifer-
ation of osteoblasts may not be directly mediated by IGF-I
but could be affected by IGF-I in a strain-dependent
manner through its interactions with TGF-b and estrogen.
The greater effect of IGF-I on bone mass, architecture, and
mechanical properties than TGF-b2 may be explained by
IGF-I having both systemic and local roles in bone
metabolism and TGF-b being a more local regulator of
bone remodeling.
Our data suggest the variation of biomechanical, micro-
architectural, and trabecular stress distribution properties of
cancellous bone in human tibiae is correlated with the vari-
ation of the concentrations of TGF-b2 and IGF-I in bone
matrix. Increased local matrix concentrations of growth
factors are associated with poor biomechanical and archi-
tectural properties of tibial cancellous bone.
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